The company has signed "definitive agreements to acquire the entire shareholding in Perrigo API India Pvt Ltd (Perrigo API India) for Rs 1,000 million," Strides Shasun said in a BSE filing.
Healthcare company Strides Shasun shares jumped more than 4 percent intraday Friday on acquisition of USFDA approved API (active pharmaceutical ingredients) facility in India.
In an interview to CNBC-TV18, Shashank Sinha, Group CEO of Strides Shasun spoke about the results and his outlook for the company.